Psoriatic Arthritis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2024

Description

List of Tables

The psoriatic arthritis treatment market is expected to grow at a CAGR of 8.2% during the forecast period of 2024 to 2032, fueled by several key factors that shape its dynamics. Advancements in drug class development, a shift towards the oral route of administration, and an evolving landscape of distribution channels are the primary drivers contributing to the market's expansion. The continuous progress in drug class development, including TNF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors, and others, has significantly impacted the market. Another key driver is the growing emphasis on the oral route of administration. The convenience and improved patient compliance associated with oral medications have led to their dominance in 2023. Yet, the forecast indicates a shift towards Parenteral administration leading in revenue, while Topical administration is expected to exhibit the highest CAGR. This reflects the changing preferences and requirements of patients, shaping the market segmentation landscape. The evolving landscape demands continuous adaptation from pharmaceutical companies to address emerging challenges and capitalize on opportunities. As the market progresses, the interplay of these factors will shape its trajectory, emphasizing the need for strategic foresight and agility in the pharmaceutical industry.

Advancements in Drug Class Development

One major driver propelling the psoriatic arthritis treatment market is the continuous advancements in drug class development. Pharmaceutical companies are investing extensively in research and development to introduce innovative therapeutic options. TNF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors, and other classes are at the forefront of this evolution. In 2023, these drug classes demonstrated remarkable revenue figures. For instance, TNF Inhibitors witnessed a surge in demand, contributing significantly to the overall market share. The strategic introduction of new drugs and formulations within these classes has not only enhanced treatment efficacy but also expanded the market's reach. The forecast for 2024 to 2032 anticipates a continued upward trajectory, highlighting the sustained importance of drug class development in shaping the psoriatic arthritis treatment market.

Growing Emphasis on Oral Route of Administration

Another driver steering the market is the growing emphasis on the oral route of administration. With technological advancements and patient preferences shifting towards convenient modes of drug delivery, the oral route has gained prominence. In 2023, oral medications, including those belonging to TNF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors, and other categories, garnered substantial revenue. The ease of administration and improved patient compliance associated with oral drugs have fueled this trend. Moreover, the forecast for 2024 to 2032 predicts a continued rise in the oral route of administration, indicating a sustained shift in consumer and healthcare provider preferences.

Evolving Landscape of Distribution Channels

The landscape of distribution channels is evolving as another influential driver of the psoriatic arthritis treatment market. Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies have emerged as key channels facilitating the availability of therapeutic options. In 2023, these channels played a pivotal role in ensuring widespread access to Psoriatic Arthritis medications. Hospital Pharmacies, in particular, demonstrated significant revenue generation owing to their role as primary healthcare institutions. Looking ahead to the forecast period from 2024 to 2032, a continuous evolution in distribution channels is expected. Online Pharmacies are anticipated to witness a surge in demand, reflecting the broader trend of digitalization in healthcare.

Restraint

High Treatment Costs

Despite the positive drivers, the market faces a notable restraint in the form of high treatment costs. The expenses associated with psoriatic arthritis treatment, including medications and supportive care, pose a significant economic burden on patients. This restraint is evidenced by the financial challenges faced by individuals seeking comprehensive treatment. The affordability barrier limits access to advanced therapies, hindering the market's full potential. Addressing the issue of high treatment costs is crucial for ensuring equitable access to psoriatic arthritis treatment.

Key Market Segmentation Analysis

Market by Drug Class

The market segmentation by Drug Class highlights TNF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors, and others as major categories. In 2023, TNF Inhibitors led in both revenue and highest CAGR, showcasing its dominance in the market. However, during the forecast period from 2024 to 2032, PDE4 Inhibitors are expected to emerge with the highest CAGR, signaling a shift in market dynamics. This differentiation emphasizes the dynamic nature of the pharmaceutical landscape and the continuous exploration of various drug classes.

Market by Route of Administration

In terms of Route of Administration, Oral medications dominated the market in 2023, accounting for both the highest revenue and CAGR. However, the forecast period anticipates a shift, with Parenteral administration projected to lead in revenue, while Topical administration is expected to exhibit the highest CAGR. This dichotomy underscores the diverse preferences and requirements of patients, shaping the market segmentation landscape.

Market by Distribution Channel

Distribution channels, including Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, play a crucial role in market dynamics. In 2023, Hospital Pharmacies led in both revenue and CAGR. However, the forecast period indicates a shift, with Online Pharmacies projected to witness the highest CAGR, while Retail Pharmacies maintain the lead in revenue. This transition highlights the increasing reliance on digital platforms for accessing psoriatic arthritis treatment.

North America Remains the Global Leader

Geographically, the psoriatic arthritis treatment market exhibits diverse trends. The region with the highest CAGR is North America, driven by a well-established healthcare infrastructure, high awareness among the population, and increasing prevalence of psoriatic arthritis. Meanwhile, Asia-Pacific emerges as the leader in revenue percentage, attributed to the large patient pool, rising healthcare investments, and improving access to advanced therapeutics. These geographic variations underscore the importance of considering regional dynamics for a comprehensive understanding of the market.

Market Competition to Intensify during the Forecast Period

Leading pharmaceutical companies, such as Pfizer, Johnson & Johnson, AbbVie, Janssen Pharmaceutical NV, Novartis AG, Amgen, Inc., Celgene Corporation, Eli Lilly and Company, Bristol Myers Squibb, and UCB S.A., have demonstrated robust revenues in 2023. Pfizer strategically expanded its product portfolio, Johnson & Johnson focused on geographical expansion, and AbbVie emphasized collaborative ventures. These strategies contributed to their respective revenue growth. Looking ahead to the forecast period from 2024 to 2032, these companies are expected to continue their strategic approaches, with anticipated revenues reflecting sustained market competitiveness.

Historical & Forecast Period

This study report represents an analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Psoriatic Arthritis Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Psoriatic Arthritis Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

Drug Class

TNF Inhibitors

Interleukin Inhibitors

PDE4 Inhibitors

Others

Route of Administration

Oral

Parenteral

Topical

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Psoriatic Arthritis Treatment market?

What are the key investment pockets concerning product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Psoriatic Arthritis Treatment market?

Which is the largest regional market for Psoriatic Arthritis Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Psoriatic Arthritis Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Psoriatic Arthritis Treatment market worldwide?

Product Code: 138008-05-24

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Psoriatic Arthritis Treatment Market
2.2. Global Psoriatic Arthritis Treatment Market, By Drug Class, 2023 (US$ Million)
2.3. Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2023 (US$ Million)
2.4. Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2023 (US$ Million)
2.5. Global Psoriatic Arthritis Treatment Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Psoriatic Arthritis Treatment Market: Competitive Analysis

3.1. Market Positioning of Key Psoriatic Arthritis Treatment Market Vendors
3.2. Strategies Adopted by Psoriatic Arthritis Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Psoriatic Arthritis Treatment Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Psoriatic Arthritis Treatment Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape

5. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
- 5.3.1. TNF Inhibitors
- 5.3.2. Interleukin Inhibitors
- 5.3.3. PDE4 Inhibitors
- 5.3.4. Others

6. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
- 6.3.1. Oral
- 6.3.2. Parenteral
- 6.3.3. Topical

7. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)

7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
- 7.3.1. Hospital Pharmacies
- 7.3.2. Retail Pharmacies
- 7.3.3. Online Pharmacies

8. North America Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)

8.1. Market Overview
8.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
8.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
8.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
8.5.Psoriatic Arthritis Treatment Market: By Region, 2022-2032, USD (Million)
- 8.5.1.North America
  - 8.5.1.1. U.S.
    - 8.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 8.5.1.1.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 8.5.1.1.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 8.5.1.2. Canada
    - 8.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 8.5.1.2.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 8.5.1.2.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 8.5.1.3. Rest of North America
    - 8.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 8.5.1.3.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 8.5.1.3.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)

9. UK and European Union Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)

9.1. Market Overview
9.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
9.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
9.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.Psoriatic Arthritis Treatment Market: By Region, 2022-2032, USD (Million)
- 9.5.1.UK and European Union
  - 9.5.1.1. UK
    - 9.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 9.5.1.1.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 9.5.1.1.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 9.5.1.2. Germany
    - 9.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 9.5.1.2.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 9.5.1.2.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 9.5.1.3. Spain
    - 9.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 9.5.1.3.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 9.5.1.3.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 9.5.1.4. Italy
    - 9.5.1.4.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 9.5.1.4.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 9.5.1.4.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 9.5.1.5. France
    - 9.5.1.5.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 9.5.1.5.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 9.5.1.5.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 9.5.1.6. Rest of Europe
    - 9.5.1.6.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 9.5.1.6.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 9.5.1.6.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)

10. Asia Pacific Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)

10.1. Market Overview
10.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
10.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
10.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.Psoriatic Arthritis Treatment Market: By Region, 2022-2032, USD (Million)
- 10.5.1.Asia Pacific
  - 10.5.1.1. China
    - 10.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 10.5.1.1.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 10.5.1.1.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 10.5.1.2. Japan
    - 10.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 10.5.1.2.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 10.5.1.2.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 10.5.1.3. India
    - 10.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 10.5.1.3.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 10.5.1.3.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 10.5.1.4. Australia
    - 10.5.1.4.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 10.5.1.4.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 10.5.1.4.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 10.5.1.5. South Korea
    - 10.5.1.5.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 10.5.1.5.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 10.5.1.5.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 10.5.1.6. Rest of Asia Pacific
    - 10.5.1.6.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 10.5.1.6.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 10.5.1.6.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)

11. Latin America Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)

11.1. Market Overview
11.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
11.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
11.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
11.5.Psoriatic Arthritis Treatment Market: By Region, 2022-2032, USD (Million)
- 11.5.1.Latin America
  - 11.5.1.1. Brazil
    - 11.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 11.5.1.1.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 11.5.1.1.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 11.5.1.2. Mexico
    - 11.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 11.5.1.2.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 11.5.1.2.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 11.5.1.3. Rest of Latin America
    - 11.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 11.5.1.3.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 11.5.1.3.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)

12. Middle East and Africa Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)

12.1. Market Overview
12.2. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
12.3. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
12.4. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
12.5.Psoriatic Arthritis Treatment Market: By Region, 2022-2032, USD (Million)
- 12.5.1.Middle East and Africa
  - 12.5.1.1. GCC
    - 12.5.1.1.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 12.5.1.1.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 12.5.1.1.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 12.5.1.2. Africa
    - 12.5.1.2.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 12.5.1.2.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 12.5.1.2.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)
  - 12.5.1.3. Rest of Middle East and Africa
    - 12.5.1.3.1. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)
    - 12.5.1.3.2. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)
    - 12.5.1.3.3. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)

13. Company Profile

13.1. Pfizer
- 13.1.1. Company Overview
- 13.1.2. Financial Performance
- 13.1.3. Product Portfolio
- 13.1.4. Strategic Initiatives
13.2. Johnson & Johnson
- 13.2.1. Company Overview
- 13.2.2. Financial Performance
- 13.2.3. Product Portfolio
- 13.2.4. Strategic Initiatives
13.3. AbbVie
- 13.3.1. Company Overview
- 13.3.2. Financial Performance
- 13.3.3. Product Portfolio
- 13.3.4. Strategic Initiatives
13.4. Janssen Pharmaceutical NV
- 13.4.1. Company Overview
- 13.4.2. Financial Performance
- 13.4.3. Product Portfolio
- 13.4.4. Strategic Initiatives
13.5. Novartis AG
- 13.5.1. Company Overview
- 13.5.2. Financial Performance
- 13.5.3. Product Portfolio
- 13.5.4. Strategic Initiatives
13.6. mgen, Inc.
- 13.6.1. Company Overview
- 13.6.2. Financial Performance
- 13.6.3. Product Portfolio
- 13.6.4. Strategic Initiatives
13.7. Celgene Corporation
- 13.7.1. Company Overview
- 13.7.2. Financial Performance
- 13.7.3. Product Portfolio
- 13.7.4. Strategic Initiatives
13.8. Eli Lilly and Company
- 13.8.1. Company Overview
- 13.8.2. Financial Performance
- 13.8.3. Product Portfolio
- 13.8.4. Strategic Initiatives
13.9. Bristol Myers Squibb
- 13.9.1. Company Overview
- 13.9.2. Financial Performance
- 13.9.3. Product Portfolio
- 13.9.4. Strategic Initiatives
13.10. UCB S.A.
- 13.10.1. Company Overview
- 13.10.2. Financial Performance
- 13.10.3. Product Portfolio
- 13.10.4. Strategic Initiatives
13.11. Other Notable Players
- 13.11.1. Company Overview
- 13.11.2. Financial Performance
- 13.11.3. Product Portfolio
- 13.11.4. Strategic Initiatives

Product Code: 138008-05-24

List of Tables

TABLE 1 Global Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 2 Global Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 3 Global Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 4 North America Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 5 North America Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 6 North America Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 7 U.S. Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 8 U.S. Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 9 U.S. Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 10 Canada Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 11 Canada Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 12 Canada Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 13 Rest of North America Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 14 Rest of North America Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 15 Rest of North America Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 16 UK and European Union Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 17 UK and European Union Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 18 UK and European Union Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 19 UK Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 20 UK Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 21 UK Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 22 Germany Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 23 Germany Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 24 Germany Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 25 Spain Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 26 Spain Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 27 Spain Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 28 Italy Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 29 Italy Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 30 Italy Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 31 France Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 32 France Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 33 France Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 34 Rest of Europe Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 35 Rest of Europe Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 36 Rest of Europe Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 37 Asia Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 38 Asia Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 39 Asia Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 40 China Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 41 China Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 42 China Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 43 Japan Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 44 Japan Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 45 Japan Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 46 India Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 47 India Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 48 India Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 49 Australia Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 50 Australia Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 51 Australia Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 52 South Korea Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 53 South Korea Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 54 South Korea Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 55 Latin America Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 56 Latin America Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 57 Latin America Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 58 Brazil Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 59 Brazil Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 60 Brazil Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 61 Mexico Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 62 Mexico Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 63 Mexico Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 64 Rest of Latin America Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 65 Rest of Latin America Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 66 Rest of Latin America Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 67 Middle East and Africa Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 68 Middle East and Africa Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 69 Middle East and Africa Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 70 GCC Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 71 GCC Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 72 GCC Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 73 Africa Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 74 Africa Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 75 Africa Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)
TABLE 76 Rest of Middle East and Africa Psoriatic Arthritis Treatment Market By Drug Class, 2022-2032, USD (Million)
TABLE 77 Rest of Middle East and Africa Psoriatic Arthritis Treatment Market By Route of Administration, 2022-2032, USD (Million)
TABLE 78 Rest of Middle East and Africa Psoriatic Arthritis Treatment Market By Distribution Channel, 2022-2032, USD (Million)

List of Figures

FIG. 1 Global Psoriatic Arthritis Treatment Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global Psoriatic Arthritis Treatment Market: Quality Assurance
FIG. 5 Global Psoriatic Arthritis Treatment Market, By Drug Class, 2023
FIG. 6 Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2023
FIG. 7 Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2023
FIG. 8 Global Psoriatic Arthritis Treatment Market, By Geography, 2023
FIG. 9 Market Geographical Opportunity Matrix - Global Psoriatic Arthritis Treatment Market, 2023

FIG. 10Market Positioning of Key Psoriatic Arthritis Treatment Market Players, 2023

FIG. 11Global Psoriatic Arthritis Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

FIG. 12 Global Psoriatic Arthritis Treatment Market, By Drug Class, 2023 Vs 2032, %
FIG. 13 Global Psoriatic Arthritis Treatment Market, By Route of Administration, 2023 Vs 2032, %
FIG. 14 Global Psoriatic Arthritis Treatment Market, By Distribution Channel, 2023 Vs 2032, %
FIG. 15 U.S. Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 16 Canada Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 17 Rest of North America Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 18 UK Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 19 Germany Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 20 Spain Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 21 Italy Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 22 France Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 23 Rest of Europe Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 24 China Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 25 Japan Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 26 India Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 27 Australia Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 28 South Korea Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 29 Rest of Asia Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 30 Brazil Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 31 Mexico Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 32 Rest of Latin America Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 33 GCC Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 34 Africa Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032
FIG. 35 Rest of Middle East and Africa Psoriatic Arthritis Treatment Market (US$ Million), 2022 - 2032

Psoriatic Arthritis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032

Description

Table of Contents

List of Tables

Table of Contents

1. Preface

2. Executive Summary

3. Psoriatic Arthritis Treatment Market: Competitive Analysis

4. Psoriatic Arthritis Treatment Market: Macro Analysis & Market Dynamics

5. Psoriatic Arthritis Treatment Market: By Drug Class, 2022-2032, USD (Million)

6. Psoriatic Arthritis Treatment Market: By Route of Administration, 2022-2032, USD (Million)

7. Psoriatic Arthritis Treatment Market: By Distribution Channel, 2022-2032, USD (Million)

8. North America Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)

9. UK and European Union Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)

10. Asia Pacific Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)

11. Latin America Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)

12. Middle East and Africa Psoriatic Arthritis Treatment Market, 2022-2032, USD (Million)

13. Company Profile

List of Tables

List of Figures